UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 8,633	$ 8,378
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	461	474
Amortization	1,898	2,064
(Gain) loss on investments	0	0
Provision for (recovery of) losses on accounts receivable	(9)	(26)
(Gain)/Loss on disposal of assets	1	4
Deferred income taxes	(359)	(414)
Stock-based compensation expense	66	49
Changes in operating assets and liabilities:
Accounts receivable	(791)	(291)
Accrued interest and other receivables	(83)	(50)
Inventories	151	(99)
Prepaid expenses and other current assets	76	22
Accounts payable	31	258
Accrued expenses	(180)	489
Total adjustments	1,262	2,480
Net cash provided by operating activities	9,895	10,858
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(151)	(953)
Capital expenditures for intangible assets	(55)	0
Net cash provided by (used in) investing activities	(206)	(953)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	298	361
Common stock purchased and retired	(683)	(1,017)
Payment of taxes for exchange of stock options	(42)	0
Tax benefit attributable to exercise of stock options	110	139
Repayment of notes payable	(4,778)	(3,052)
Payment of dividends	(1,914)	(1,874)
Net cash provided by (used in) financing activities	(7,009)	(5,443)
Effect of exchange rate changes on cash	(332)	(609)
Net increase in cash and cash equivalents	2,348	3,853
Cash at beginning of period	19,274	14,395
Cash at end of period	21,622	18,248
Cash paid during the period for income taxes	4,030	2,492
Cash paid during the period for interest	$ 65	$ 239